Shareholders' Equity - Restricted Stock (Details) - Restricted Stock Unit - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period			3 years
Stock based compensation expense	$ 376,613	$ 309,109	$ 1,148,289	$ 944,267
Compensation cost not yet recognized	$ 2,050,180		$ 2,050,180		$ 3,198,469
Weighted average period for recognition			1 year		1 year 3 months 18 days
Number outstanding
Balance non-vested Stock at beginning of period (in shares)			560,970	491,536	491,536
Granted (in shares)			0		300,052
Vested (in shares)			(49,808)		(230,618)
Balance non-vested Stock at end of period (in shares)	511,162		511,162		560,970	491,536
Weighted Average Remaining Life
Balance non-vested Stock at end of period (in years)			11 months 12 days		1 year 7 months 9 days	1 year 8 months 26 days
Granted (in years)					1 year 11 months 1 day
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value , beginning of period			$ 5.77	$ 5.59	$ 5.59
Weighted Average Grant Date Fair Value, Granted			0		5.97
Weighted Average Grant Date Fair Value, Vested			5.72		5.65
Weighted Average Grant Date Fair Value, end of period	$ 5.78		$ 5.78		$ 5.77	$ 5.59
Board of Directors
Number outstanding
Granted (in shares)			0
Management, Employees, and Board Of Directors
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average market price at grant date (in dollars per share)					$ 5.97
Number outstanding
Granted (in shares)					300,052